Next Article in Journal / Special Issue
Anodic Oxidation and Amperometric Sensing of Hydrazine at a Glassy Carbon Electrode Modified with Cobalt (II) Phthalocyanine–cobalt (II) Tetraphenylporphyrin (CoPc- (CoTPP)4) Supramolecular Complex
Previous Article in Journal
Solid State pH Sensor Based on Light Emitting Diodes (LED) As Detector Platform
Previous Article in Special Issue
Thermally Stable Merocyanine Form of Photochromic Spiropyran with Aluminum Ion as a Reversible Photo-driven Sensor in Aqueous Solution
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nucleoside Sensing

by
Michael Fokkens
1,
Frank-Gerrit Klärner
2,* and
Thomas Schrader
1,*
1
Marburg University, Department of Chemistry, Hans-Meerwein-Strasse, 35032 Marburg, Germany
2
Duisburg-Essen University, Institute of Organic Chemistry, Universitätsstr. 5, 45117 Essen, Germany
*
Authors to whom correspondence should be addressed.
Sensors 2006, 6(8), 860-873; https://doi.org/10.3390/s6080860
Submission received: 5 April 2006 / Accepted: 7 June 2006 / Published: 24 August 2006
(This article belongs to the Special Issue Supramolecular Sensors)

Abstract

:
A rigid molecular clip comprising bisphosphonate binding sites and aromatic sidewalls forming an electron-rich cavity is able to distinguish between nucleosides and nucleotides in aqueous solution. Neutral nucleosides as well as antibiotics derived thereof are drawn into the unpolar interior of the cleft and lead to substantial upfield-shifts in the 1H NMR spectrum. Nucleoside drugs can therefore be detected with high selectivity in the presence of their phosphorylated pendants or nucleic acids.

1. Introduction

Nucleoside drugs are of paramount importance in aids or cancer therapy due to their antiviral or antitumor activity. Since it is virtually impossible for highly polar phosphorylated species to pass cell membranes, the respective drugs are administrered as neutral nucleosides, and subsequently activated by intracellular conversion into the 5′-triphosphates. A much more elegant approach is the design of Trojan horses, which are masked nucleotides, i. e., neutral lipophilic prodrugs with decreased polarity [1]. However, even for the nucleosides, it is difficult to pass the blood brain barrier [2], so that carrier molecules are needed which may act as potent transporters. The programmed switch between a neutral and a phosphorylated state poses the challenge to develop selective detection methods. Few examples are available for nucleotide-selective hosts in water, inter alia, based on cyclophane scaffolds [3]. High binding constants (micromolar Kd values) were especially achieved with receptor molecules containing a central phenanthridinium system [4]. To the best of our knowledge, however, no selective artificial receptor molecule has been presented to date which is able to recognize a neutral nucleotide in the presence of an anionic nucleotide. Over the past decades, Klärner et al. have created a large number of rigid molecular clips and tweezers, comprising an electron-rich cavity which is able to accomodate unpolar or cationic small guest molecules [5]. In a cooperation, we have recently rendered the parent molecular clip water-soluble by adorning the central benzene ring with methyl phosphonate functionalities and found efficient binding of cationic aromatic substrates such as NAD+ (Figure 1) [6]. Now we discovered that neutral electron-deficient guests are also included inside the electron-rich cavity. The question arose, if these molecules could indeed be utilized for nucleoside sensing.

2. Results and Discussion

NMR titrations indicate inclusion in the clip cavity by substantial upfield shifts of all guest protons involved. They also allow determination of binding constants and estimation of the binding mode [7]. All nucleosides and mononucleotides were tested systematically - the respective Ka values are listed in Figure 2. At first glance it becomes evident, that only the neutral nucleoside candidates are bound by the clip, whereas the negatively charged nucleotides are rejected, except for AMP. The reason is obviously electrostatic repulsion between the host and guest phosph(on)ate moieties. Nucleosides are bound with Ka values between 2000 and 7000 M-1, most likely depending on the size of their π-face as well as their electrostatic potential surface (Figure 3). Carbonyl groups are counterproductive due to their large dipole moment - and lead to repulsion from the electron-rich inner cavity wall. Since large π-faces are hard to desolvate in aqueous solution, the nonpolar microenvironment of the clip cavity greatly facilitates this process and leads to a positive free energy balance of the inclusion process.
Upfield shifts in the nucleic bases amount to 1-2 ppm (Δδmax), whereas those in the ribose part are small (0-0.2 ppm), indicating that the aromatic electron-poor heterocycle is preferentially bound by the clip and the much more polar ribose part remains oriented towards the solvent. The exact orientation inside the cavity has in related cases already been calculated very successfully with quantum chemical methods, and could definitely be applied to these interesting complexes as well [8]. By contrast, except for AMP with its relatively large π-face no chemical shift changes were observed after equilibration with nucleotide guests, irrespective of the number of phophate groups present (Δδ < 0.03 ppm). Thus, mono-, di- and triphosphates such as ATP are all rejected by the clip. This renders 1 highly selective for nucleosides.
Nucleoside antibiotics such as 3′-azido-2′,3′-dideoxythymidine (AZT) and 2′,3′-didehydro-2′,3′-dideoxythymidine (ddT) are highly potent inhibitors of the human immunodeficiency virus HIV [9]. These also bind to the clip, albeit with lowered affinity. Obviously, the altered ribose skeleton poses steric constraints on the inclusion of the heterocyclic fragment. Probable complex geometries, which are in agreement with NMR data, are depicted in Figure 4.
In the future, we intend to test, if the complex of a nucleoside inside the clip penetrates membranes more easily than the drug itself. If successful, the clip could be further modified to carry additional lipophilic groups and be used as a carrier for nucleoside drugs across the BBB. Precomplexation of a solvatochromic dye within the clip cavity which is subsequently released on nucleoside binding and thereby changes its color, would lead to a real sensor system with a quantifyable visible readout. Experiments in this direction are underway in our laboratories.

3. Experimental Section

Synthetic details on the preparation of clip 1: see ref. 6 and 8.
General procedure for NMR titrations with clip 1 and nucleos(t)ide guests:
a)
dilution titration: host and guest were dissolved as a 1:1 mixture in D2O and an NMR spectrum was measured. Subsequently, the solution was diluted several times with D2O. Pure host as well as pure guest solutions of varying concentrations were also measured and compared with respect to their proton shifts. Only those proton signals which are insensitive towards dilution, can be used as probes. All NMR spectra were routinely calibrated onto the rest proton signal of the deuterated solvent (D2O: 4.700 ppm). The corresponding binding constants and Δδsat values were obtained by standard nonlinear regression.
b)
conventional titration: ten NMR tubes were filled each with the same amount of a solution of the guest in D2O. The host solution (D2O) was added in increasing volume increments to tubes 2-10. All tubes were subsequently filled with pure solvent to the very same total volume to exclude potential dilution effects. Tube 1 served as the reference. The guest concentration was estimated at the reciprocal value of the expected association constant (Kd). NMR spectra were calibrated onto the rest proton signal of the deuterated solvent (D2O: 4.700 ppm). The corresponding binding constants and Δδsat values were obtained by standard nonlinear regression.

Job plots

The samples from the conventional NMR titrations with constant concentrations and varying host and guest ratios were used for the indirect determination of the complex stoichiometries from their respective molar fractions. These were multiplied with Δδ and plotted against the molar fraction itself. Maxima indicate the molar fraction of host or guest which produce the largest complex concentration and therefore simultaneously indicate the complex stoichiometry.

Molecular Modeling

The program MacroModel 7.1 was used for model building procedures and as graphical interface. Force-field parameters were taken from the built-in force fields, OPLS-AA or Amber* were chosen for all minimizations and Monte Carlo simulations. Minimizations and Monte Carlo simulations were carried out in aqueous solution. Energy minimizations were conducted over 1000 iterations on a Silicon Graphics O2 workstation. The best structures were subjected to conformational searches with 5000 or 10000-step Monte Carlo simulations.

Acknowledgments

We gratefully acknowledge supply with AZT and ddT by Prof. Chris Meier, Hamburg.

Supplementary Information

Dilution titration between clip 1 and 2′-deoxythymidine

Parent solution: 0.745 mg (0.690 μmol) host 1 and 0.370 mg (1.526 μmol) 2′-deoxythymidine in 500 μL D2O.
entryVparent solution (μL)Vtotal (μL)cguest (mol/L)chost (mol/L)δa (ppm)δb (ppm)δc (ppm)δd (ppm)δe (ppm)
0reference5003.05·10-31.38·10-37.61066.26001.85457.67477.3326
1255001.53·10-46.90·10-57.53986.24011.82137.65927.3011
2505003.05·10-41.38·10-47.49236.22461.79297.65037.3000
3755004.58·10-42.07·10-47.47356.21801.78607.64817.2867
41255007.63·10-43.45·10-47.44486.20691.76727.64267.2801
52505001.53·10-36.90·10-47.40726.19141.74517.63397.2679
65005003.05·10-31.38·10-37.37516.17601.72637.61947.2525

Δδsat (ppm)0.6184 ± 2%0.2379 ± 2%0.3495 ± 3%0.0617 ± 5%0.0869 ± 5%

Ka (mol/L)2701 ± 6%1707 ± 7%2184 ± 10%2162 ± 16%3064 ± 21%
Sensors 06 00860f5

Dilution titration of clip 1 with 2′-deoxyguanosine

Parent solution: 0.745 mg (0.690 μmol) host 1 and 0.416 mg (1.459 μmol) 2′-deoxyguanosine in 600 μL D2O.
entryVparent solution (μL)Vtotal (μL)cguest (mol/L)chost (mol/L)δa (ppm)δb (ppm)
0reference6002.43·10-3-8.02126.3408
1306001.22·10-45.77·10-57.99106.3203
2606002.43·10-41.15·10-47.98486.3070
3906003.65·10-41.73·10-47.96506.3012
41506006.08·10-42.89·10-47.95116.2896
53006001.22·10-35.77·10-47.93036.2717
66006002.43·10-31.12·10-37.91246.2532

Δδsat (ppm)0.3033 ± 5%0.2480 ± 4%

Ka (mol/L)2000 ± 13%1718 ± 9%
Sensors 06 00860f6

Dilution titration of clip 1 with 2′-deoxyadenosine

Parent solution: 0.745 mg (0.690 μmol) host 1 and 0.239 mg (0.922 μmol) 2′-deoxyadenosine in 500 μL D2O.
entryVparent solution (μL)Vtotal (μL)cguest (mol/L)chost (mol/L)δa (ppm)δb (ppm)δc (ppm)δd (ppm)δe (ppm)δf (ppm)
0reference5001.84·10-31.38·10-38.29038.20966.45567.69577.67477.3326
1255009.22·10-56.90·10-58.15998.13556.40597.65147.62387.2701
2505001.84·10-41.38·10-48.09808.09806.38267.64267.61177.2525
3755002.77·10-42.07·10-48.08368.06926.36947.63937.60727.2436
41255004.61·10-43.45·10-48.06158.02616.35177.63167.60177.2292
52505009.22·10-46.90·10-48.03167.97096.32757.62057.58187.2094
65005001.84·10-31.38·10-38.00517.92896.29977.60507.56637.2884

Δδsat (ppm)0.5955 ± 1%0.3318 ± 2%0.2660 ± 3%0.1308 ± 6%0.1602 ± 6%0.1662 ± 4%

Ka (mol/L)5771 ± 3%6068 ± 6%4115 ± 8%10300 ± 25%9076 ± 25%7710 ± 14%
(averaged Ka value only from guest signals)
Sensors 06 00860f7

Dilution titration of clip 1 with 2′-deoxyuridine

Parent solution: 0.745 mg (0.690 μmol) host 1 and 0.220 mg (0.965 μmol) 2′-deoxyuridine in 700 μL D2O.
entryVparent solution (μL)Vtotal (μL)cguest (mol/L)chost (mol/L)δa (ppm)δb (ppm)
0reference6001.61·10-3-6.23395.8324
1306008.05·10-55.77·10-5-5.6402
2606001.61·10-41.15·10-46.20055.5505
3906002.41·10-41.73·10-46.18775.4730
43006008.04·10-45.77·10-46.14465.1885
56006001.61·10-31.12·10-36.12865.1079

Δδsat (ppm)1.465 ± 5%0.2384 ± 6%

Ka (mol/L)3012 ± 12%1922 ± 16%
Sensors 06 00860f8

Dilution titration of clip 1 with 2′-deoxycytidine

Parent solution: 0.745 mg (0.690 μmol) host 1 and 0.194 mg (0.793 μmol) 2′-deoxycitidine in 600 μL D2O.
entryVparent solution (μL)Vtotal (μL)cguest (mol/L)chost (mol/L)δa (ppm)δb (ppm)δc (ppm)
0reference6001.32·10-3-7.84926.30086.0741
1306006.61·10-55.77·10-57.72096.26655.8807
2606001.32·10-41.15·10-4-6.24815.7873
3906001.98·10-41.73·10-47.65276.23815.7319
42506003.30·10-42.89·10-47.60966.22395.6595
53006006.61·10-45.77·10-47.56156.20745.5775
66006001.32·10-31.15·10-37.52446.19455.5133

Δδsat (ppm)0.4738 ± 2%0.1646 ± 1%0.8499 ± 1%

Ka (mol/L)8545 ± 8%6332 ± 4%7197 ± 3%
Sensors 06 00860f9

Dilution titration of clip 1 with AMP

Parent solution: 0.768 mg (0.713 μmol) host 1 and 0.281 mg (0.718 μmol) AMP in 500 μL D2O.
entryVparent solution (μL)Vtotal (μL)cguest (mol/L)chost (mol/L)δa (ppm)
0reference5001.44·10-3-8.2317
1255007.18·10-57.13·10-58.2184
2505001.44·10-41.43·10-48.2096
3755002.15·10-42.14·10-48.2052
41005002.87·10-42.85·10-48.1919
51255003.59·10-43.56·10-48.1875
62505007.18·10-47.13·10-48.1615
75005001.44·10-31.43·10-48.1477

Δδsat (ppm)0.1881 ± 10%

Ka (mol/L)1126 ± 19%
Sensors 06 00860f10

Dilution titration of clip 1 with AZT

Parent solution: 0.433 mg (0.714 μmol) host 1 and 0.190 mg (0.717 μmol) AZT in 600 μL D2O.
entryVparent solution (μL)Vtotal (μL)cguest (mol/L)chost (mol/L)δa (ppm)δb (ppm)δc (ppm)
0reference6001.20·10-3-7.62006.19361.6839
1306005.98·10-55.95·10-57.50226.14611.8059
2606001.20·10-41.19·10-47.40506.10961.7650
3906001.79·10-41.79·10-57.30116.06881.7219
41206002.39·10-42.38·10-47.22596.03891.6865
51506002.98·10-42.98·10-47.16966.01791.6622
63006005.98·10-45.95·10-46.82695.87521.4842
76006001.20·10-31.19·10-36.24645.76591.3759

Δδsat (ppm)3.116 ± 6%1.245 ± 8%1.400 ± 11%

Ka (mol/L)707 ± 11%696 ± 14%730 ± 19%
Sensors 06 00860f11

Titration of clip 1 with 2′,3′-deoxythymidine

Host solution: 1.593 mg (2.629·10-6 mol) host 1 in 650 μL D2O.
Guest solution: 0.435 mg (1.944·10-6 mol) 2′,3′-deoxythymidine in 750 μL D2O.
entryVguest (μL)Vhost (μL)Vtotal (μL)cguest (mol/L)chost (mol/L)δa (ppm)δb (ppm)δc (ppm)δd (ppm)δf (ppm)
07506003.24·10-407.64176.96926.48775.98241.8810
175106003.24·10-46.74·10-57.63126.96326.47905.97651.8719
275206003.24·10-41.35·10-47.61106.95366.47585.96931.8545
375306003.24·10-42.02·10-47.59736.94546.46995.96231.8426
475406003.24·10-42.70·10-47.57989.93766.46345.95591.8274
575506003.24·10-43.37·10-47.56119.92806.45385,94531.8114
675606003.24·10-44.04·10-47.54506.92116.44925,93891.7977
775806003.24·10-45.39·10-47.51336.90786.43835,92751.7720
8751206003.24·10-48.09·10-47.45896.87996.41405,9000-
9752006003.24·10-41.35·10-37.36186.83506.37645,85651.6415

Δδsat (ppm)1.645 ± 17%0.6014 ± 9%0.6108 ± 18%0.8318 ± 19%1.399 ± 20%

Ka (mol/L)160 ± 20%226 ± 12%174 ± 21%138 ± 23%160 ± 20%
Sensors 06 00860f12

References and Notes

  1. Meier, C. Mini Reviews in Medicinal Chemistry 2002, 2, 219–234.
  2. Wu, D.; Clement, J.G.; Pardridge, W. M. Brain Res. 1998, 791, 313–316.
  3. Rotger, M.C.; González, J. F.; Ballester, P.; Deyà, P. M.; Costa, A. J. Org. Chem. 1994, 59, 4501–4505.
  4. Cudic, P.; Žinic, M.; Tomišic, V.; Simeon, V.; Vigneron, J.-P.; Lehn, J.-M. J. Chem. Soc., Chem. Commun. 1995, 1073–1075.
  5. Klärner, F.-G.; Kahlert, B. Acc. Chem. Res. 2003, 36, 919–932.
  6. Jasper, C.; Schrader, T.; Panitzky, J.; Klärner, F.-G. Angew. Chem. 2002, 114, 1411–1415.
  7. Connors, K. A. Binding Constants, The Measurement of Molecular Complex Stability; Wiley: New York, 1987. [Google Scholar]Fielding, L. Tetrahedron 2000, 56, 6151–6170.
  8. Fokkens, M.; Jasper, C.; Schrader, T.; Koziol, F.; Ochsenfeld, C.; Polkowska, J.; Lobert, M.; Kahlert, B.; Klärner, F.-G. Chem. Eur. J. 2005, 11, 477–494.
  9. Balzarini, J.; Herdewijn, P.; De Clercq, E. J. Biol. Chem. 1989, 264, 6127–6133.
Figure 1. Calculated as well as Lewis structure and electrostatic potential surface of the water-soluble molecular clip 1.
Figure 1. Calculated as well as Lewis structure and electrostatic potential surface of the water-soluble molecular clip 1.
Sensors 06 00860f1
Figure 2. Nucleosides bound by clip 1, with corresponding binding constants [M-1] and maximum chemical shift changes Δδmax [ppm].
Figure 2. Nucleosides bound by clip 1, with corresponding binding constants [M-1] and maximum chemical shift changes Δδmax [ppm].
Sensors 06 00860f2
Figure 3. Electrostatic Potential Surface (EPS) of the nucleic bases calculated with PM3 showing the varying distribution of electron density on their respective π-faces (EPS color code: - 25 kcal/mol: red; + 25 kcal/mol: blue).
Figure 3. Electrostatic Potential Surface (EPS) of the nucleic bases calculated with PM3 showing the varying distribution of electron density on their respective π-faces (EPS color code: - 25 kcal/mol: red; + 25 kcal/mol: blue).
Sensors 06 00860f3
Figure 4. a) Nucleoside antibiotics AZT and ddT bound by clip 1, with corresponding binding constants [M-1] and maximum chemical shift changes Δδmax [ppm].b) Calculated complex structures for clip 1 + AZT (left) and clip 1 + 2′,3′-didehydro-2′,3′-dideoxythymidine (ddT, right): MacroModel 7.1, OPLS-AA, H2O, Monte-Carlo simulation with 2000 steps.
Figure 4. a) Nucleoside antibiotics AZT and ddT bound by clip 1, with corresponding binding constants [M-1] and maximum chemical shift changes Δδmax [ppm].b) Calculated complex structures for clip 1 + AZT (left) and clip 1 + 2′,3′-didehydro-2′,3′-dideoxythymidine (ddT, right): MacroModel 7.1, OPLS-AA, H2O, Monte-Carlo simulation with 2000 steps.
Sensors 06 00860f4aSensors 06 00860f4b

Share and Cite

MDPI and ACS Style

Fokkens, M.; Klärner, F.-G.; Schrader, T. Nucleoside Sensing. Sensors 2006, 6, 860-873. https://doi.org/10.3390/s6080860

AMA Style

Fokkens M, Klärner F-G, Schrader T. Nucleoside Sensing. Sensors. 2006; 6(8):860-873. https://doi.org/10.3390/s6080860

Chicago/Turabian Style

Fokkens, Michael, Frank-Gerrit Klärner, and Thomas Schrader. 2006. "Nucleoside Sensing" Sensors 6, no. 8: 860-873. https://doi.org/10.3390/s6080860

Article Metrics

Back to TopTop